Nicholas I. Paton

4.5k total citations · 2 hit papers
39 papers, 2.7k citations indexed

About

Nicholas I. Paton is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Nicholas I. Paton has authored 39 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 21 papers in Virology and 19 papers in Emergency Medicine. Recurrent topics in Nicholas I. Paton's work include HIV Research and Treatment (21 papers), HIV/AIDS drug development and treatment (21 papers) and HIV-related health complications and treatments (19 papers). Nicholas I. Paton is often cited by papers focused on HIV Research and Treatment (21 papers), HIV/AIDS drug development and treatment (21 papers) and HIV-related health complications and treatments (19 papers). Nicholas I. Paton collaborates with scholars based in United Kingdom, Singapore and Denmark. Nicholas I. Paton's co-authors include Jacqueline Neuhaus, Russell P. Tracy, Lewis H. Kuller, Daniel E. Nixon, Bruno Ledergerber, Waldo Belloso, Fraser Drummond, Jens Lundgren, H. Clifford Lane and James D. Neaton and has published in prestigious journals such as The Lancet, JAMA and PLoS ONE.

In The Last Decade

Nicholas I. Paton

37 papers receiving 2.7k citations

Hit Papers

Inflammatory and Coagulation Biomarkers and Mortality in ... 2008 2026 2014 2020 2008 2012 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
    2008 1.2k citations Lewis H. Kuller, Russell P. Tracy et al. PLoS Medicine profile →
  2. Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals
    2012 419 citations Daniel Duprez, Jacqueline Neuhaus et al. PLoS ONE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas I. Paton United Kingdom 18 1.7k 1.4k 1.4k 493 256 39 2.7k
Fraser Drummond Australia 11 1.5k 0.9× 1.2k 0.8× 1.1k 0.8× 508 1.0× 225 0.9× 18 2.2k
P. Mercié France 31 1.2k 0.7× 1.4k 1.0× 889 0.6× 619 1.3× 175 0.7× 122 2.9k
Daniel E. Nixon United States 18 2.0k 1.2× 1.6k 1.1× 1.7k 1.3× 1.0k 2.1× 480 1.9× 32 3.3k
Jason V. Baker United States 33 2.2k 1.3× 1.9k 1.4× 1.7k 1.2× 856 1.7× 384 1.5× 103 3.7k
Jacqueline Neuhaus United States 24 2.8k 1.6× 2.2k 1.5× 1.9k 1.4× 981 2.0× 370 1.4× 38 4.2k
Fabrice Bonnet France 38 1.4k 0.8× 2.1k 1.5× 1.1k 0.8× 1.5k 3.1× 254 1.0× 173 4.4k
Philippe Morlat France 33 1.5k 0.9× 2.1k 1.5× 1.0k 0.8× 1.8k 3.6× 171 0.7× 109 4.2k
Gilbert R. Kaufmann Australia 24 1.4k 0.8× 2.3k 1.6× 2.2k 1.6× 755 1.5× 494 1.9× 46 3.4k
Andrew Carr Australia 26 2.3k 1.4× 2.5k 1.7× 1.9k 1.4× 749 1.5× 76 0.3× 64 3.8k
Adam Rupert United States 25 852 0.5× 891 0.6× 956 0.7× 603 1.2× 464 1.8× 66 2.1k

Countries citing papers authored by Nicholas I. Paton

Since Specialization
Citations

This map shows the geographic impact of Nicholas I. Paton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas I. Paton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas I. Paton more than expected).

Fields of papers citing papers by Nicholas I. Paton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas I. Paton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas I. Paton. The network helps show where Nicholas I. Paton may publish in the future.

Co-authorship network of co-authors of Nicholas I. Paton

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas I. Paton. A scholar is included among the top collaborators of Nicholas I. Paton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas I. Paton. Nicholas I. Paton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hart, Melanie, Mark Gompels, Alan Winston, et al.. (2023). Peripheral Neuropathy in Virologically Suppressed People Living with HIV: Evidence from the PIVOT Trial. Viruses. 16(1). 2–2.
2.
Thompson, JA, et al.. (2019). Mapping the medical outcomes study HIV health survey (MOS-HIV) to the EuroQoL 5 Dimension (EQ-5D-3 L) utility index. Health and Quality of Life Outcomes. 17(1). 83–83. 9 indexed citations
3.
Dunn, David, Wolfgang Stöhr, Alejandro Arenas‐Pinto, et al.. (2018). Next generation sequencing of HIV-1 protease in the PIVOT trial of protease inhibitor monotherapy. Journal of Clinical Virology. 101. 63–65. 6 indexed citations
4.
Kityo, Cissy, JA Thompson, Immaculate Nankya, et al.. (2017). HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 75(2). e45–e54. 22 indexed citations
5.
Walker, Simon, Wolfgang Stöhr, David Dunn, et al.. (2016). Cost Effectiveness of Protease Inhibitor Monotherapy Versus Standard Triple Therapy in the Long-Term Management of HIV Patients: Analysis Using Evidence from the PIVOT Trial. PharmacoEconomics. 34(8). 795–804. 7 indexed citations
6.
7.
Stöhr, Wolfgang, David Dunn, Alejandro Arenas‐Pinto, et al.. (2016). Factors associated with virological rebound in HIV-infected patients receiving protease inhibitor monotherapy. AIDS. 30(17). 2617–2624. 14 indexed citations
8.
Arribas, José Ramón, PM Girard, Nicholas I. Paton, et al.. (2015). Efficacy of protease inhibitor monotherapy vs . triple therapy: meta‐analysis of data from 2303 patients in 13 randomized trials. HIV Medicine. 17(5). 358–367. 40 indexed citations
9.
Paton, Nicholas I., Wolfgang Stöhr, Alejandro Arenas‐Pinto, et al.. (2015). Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial. The Lancet HIV. 2(10). e417–e426. 55 indexed citations
10.
Arenas‐Pinto, Alejandro, JA Thompson, Godfrey Musoro, et al.. (2015). Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trial. Journal of NeuroVirology. 22(1). 104–113. 27 indexed citations
11.
Kambugu, Andrew, JA Thompson, James Hakim, et al.. (2015). Neurocognitive Function at the First-Line Failure and on the Second-Line Antiretroviral Therapy in Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 71(5). 506–513. 5 indexed citations
12.
Walker, Susan, et al.. (2014). Cost-Effectiveness Analysis of Protease Inhibitor Monotherapy Verse Ongoing Triple-Therapy in the Long-Term Management of HIV Patients. Value in Health. 17(7). A683–A683. 1 indexed citations
13.
Arribas, José Ramón, Pierre‐Marie Girard, Nicholas I. Paton, et al.. (2014). Efficacy of PI monotherapy versus triple therapy for 1964 patients in 10 randomised trials. Journal of the International AIDS Society. 17(4S3). 19788–19788. 17 indexed citations
14.
Winston, Alan, Alejandro Arenas‐Pinto, Wolfgang Stöhr, et al.. (2013). Neurocognitive Function in HIV Infected Patients on Antiretroviral Therapy. PLoS ONE. 8(4). e61949–e61949. 53 indexed citations
15.
Baker, Jason V., Jacqueline Neuhaus, Daniel Duprez, et al.. (2010). Changes in Inflammatory and Coagulation Biomarkers: A Randomized Comparison of Immediate versus Deferred Antiretroviral Therapy in Patients With HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 56(1). 36–43. 125 indexed citations
16.
Duprez, Daniel, Lewis H. Kuller, Russell P. Tracy, et al.. (2009). Lipoprotein particle subclasses, cardiovascular disease and HIV infection. Atherosclerosis. 207(2). 524–529. 98 indexed citations
17.
Kuller, Lewis H., Russell P. Tracy, Waldo Belloso, et al.. (2008). Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection. PLoS Medicine. 5(10). e203–e203. 1231 indexed citations breakdown →
18.
Paton, Nicholas I.. (2008). Treatment interruption strategies: how great are the risks?. Current Opinion in Infectious Diseases. 21(1). 25–30. 12 indexed citations
19.
20.
Griffin, George E., Nicholas I. Paton, Kamyar Arasteh, et al.. (1998). 2nd Workshop on Nutrition and Quality of Life in HIV Infection: The Role of Growth Hormone in HIV-associated Wasting, Berlin, Germany, 6-7 March, 1998. 1. 199–218. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fraser Drummond Breakdown of academic impact, for papers by P. Mercié Breakdown of academic impact, for papers by Daniel E. Nixon Breakdown of academic impact, for papers by Jason V. Baker Breakdown of academic impact, for papers by Jacqueline Neuhaus Breakdown of academic impact, for papers by Fabrice Bonnet Breakdown of academic impact, for papers by Philippe Morlat Breakdown of academic impact, for papers by Gilbert R. Kaufmann Breakdown of academic impact, for papers by Andrew Carr Breakdown of academic impact, for papers by Adam Rupert
Rankless by CCL
2026